AI-generated summary
The authors irradiated human breast carcinoma, melanoma, and immortalized mammary epithelial cell lines in vitro with laser light at 780, 830, or 904 nm and measured proliferation 24 hours later. They report that certain doses increased proliferation in one breast cancer cell line, while repeated exposures had no effect or a negative dose response, and no malignant transformation was detected. The authors state that further in vivo research is needed before the safety of laser therapy for breast cancer-related lymphoedema can be concluded.
- Who or what was studied
- Human breast carcinoma, melanoma, and immortalized human mammary epithelial cell lines, plus murine NIH3T3 fibroblasts, studied in vitro
- Wavelengths
- 780, 830, 904 nm
- Limits stated in the abstract
- The study was conducted in vitro on cell lines only, and the authors state that in vivo research is required before safety can be concluded.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 904 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Phototherapy, Wavelength, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.